Oxolamine, with the CAS number 959-14-8, is a chemical compound that belongs to the class of amines. It is characterized by its structure, which includes a hydroxyl group and an amine functional group, contributing to its potential as a pharmaceutical agent. Oxolamine is primarily recognized for its use as an antitussive, meaning it is utilized to suppress coughs. The compound exhibits properties that allow it to interact with the central nervous system, providing relief from cough symptoms. Additionally, it may possess anti-inflammatory and analgesic effects, making it relevant in the treatment of respiratory conditions. Oxolamine is typically administered in various formulations, including syrups and tablets, and is often combined with other active ingredients to enhance its therapeutic efficacy. As with many pharmacological agents, the safety profile and potential side effects are important considerations in its use, necessitating careful dosage and monitoring. Overall, oxolamine serves as a notable example of a compound with specific medicinal applications in respiratory health.

Oxolamine

959-14-8: 1,2,4-Oxadiazole, 5-[2-(diethylamino)ethyl]-3-phenyl-, 1,2,4-Oxadiazole-5-ethanamine, N,N-diethyl-3-phenyl-, 3-Phenyl-5-(β-diethylaminoethyl)-1,2,4-oxadiazole, 5-(2-Diethylaminoethyl)-3-Phenyl-1,2,4-Oxadiazole, N,N-Diethyl-3-phenyl-1,2,4-oxadiazole-5-ethanamine, Oxolamine

Oxolamine is a microcapsule formulation of the anticoagulant heparin. Heparin is a natural polysaccharide that inhibits the formation of blood clots. Oxolamine is administered by injection and is used to prevent or treat deep vein thrombosis, pulmonary embolism, and other conditions associated with coagulation disorders. It has been shown that the drug has an anticoagulant effect in Sprague-Dawley rats with autoimmune diseases and inflammatory bowel disease. The drug also has proteolytic activity, which may be responsible for its water-vapor-producing effects. Oxolamine has not been approved for use as a pharmaceutical dosage form; however, it can be obtained through prescription as a treatment for bowel disease.

CAS 959-14-8: Oxolamine

Oxolamine

Ref: 3D-AAA95914

Oxolamine

Ref: TM-T20056